Glioblastoma Multiforme
📧 Sign up to get email alerts when something new happens for Glioblastoma Multiforme.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma [Phase 1, Phase 2]
Phase 1/2 trial evaluating combinations of sorafenib with erlotinib, tipifarnib, or temsirolimus in adults with recurrent glioblastoma multi…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Temozolomide During and After Radiation Therapy in Treating Patients Who Have Undergone Previous Surgery and Placement of Gliadel Wafers for Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating temozolomide given during and after radiotherapy in patients with newly diagnosed glioblastoma multiforme who had…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1]
Phase 1 trial evaluating veliparib (ABT-888) with radiation therapy and temozolomide in newly diagnosed glioblastoma multiforme has complete…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme [Phase 1]
Phase 1 study of gadolinium texaphyrin in combination with radiation therapy for supratentorial glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM) [EARLY_Phase 1]
An early-phase exploratory trial evaluating immune modulation by VEGF blockade in glioblastoma multiforme; the study has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor [Phase 1]
Phase 1 study evaluating Tocagen's retroviral replicating vector Toca 511 in combination with the prodrug 5-fluorocytosine for recurrent mal…
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor [Phase 1]
This document reports the completion of a Phase 1 trial evaluating a retroviral replicating vector (Toca 511) given intravenously to patient…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: A Dose-finding Study of Birabresib (MK-8628) in Participants With Recurrent Glioblastoma Multiforme (MK-8628-002) [Phase 2]
Phase 2 dose-finding study of birabresib (MK-8628) in recurrent glioblastoma multiforme was terminated; results were posted.
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Immunotoxin Therapy in Treating Children With Progressive or Recurrent Glioblastoma Multiforme or Anaplastic Astrocytoma [Phase 1]
Phase 1 clinical trial evaluating an immunotoxin therapy in children with progressive or recurrent glioblastoma multiforme or anaplastic ast…
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: A Study Using Allogenic-Cytomegalovirus (CMV) Specific Cells for Glioblastoma Multiforme (GBM) [Phase 1]
A Phase 1 trial evaluating allogeneic CMV-specific cytotoxic T cells for glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-04-25Clinical Trial Update: Boron Neutron Capture Therapy, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating the combination of boron neutron capture therapy, radiation therapy, and temozolomide for newly diagnosed gliobla…
-
CLINICAL_TRIALS trial_result · 2018-03-30Clinical Trial Update: A Feasibility Study of the Nativis Voyager® System in Patients With Recurrent Glioblastoma Multiforme (GBM) in Australia [NA]
This document reports the completion of a feasibility study evaluating the Nativis Voyager System in patients with recurrent glioblastoma mu…
-
CLINICAL_TRIALS trial_result · 2018-01-31Clinical Trial Update: Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating BKM120 (buparlisib) in combination with bevacizumab for relapsed/refractory glioblastoma multiforme a…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 3]
Phase 3 trial evaluating radiation therapy with or without temozolomide in older adults with newly diagnosed glioblastoma multiforme has com…
-
CLINICAL_TRIALS trial_result · 2018-01-23Clinical Trial Update: Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
Clinical trial evaluating everolimus, temozolomide, and radiation therapy for newly diagnosed glioblastoma multiforme (Phase 1/2) completed …
-
CLINICAL_TRIALS trial_result · 2018-01-16Clinical Trial Update: Phase II Study of Rindopepimut (CDX-110) in Patients With Glioblastoma Multiforme [Phase 2]
Phase II study of rindopepimut (CDX-110) in glioblastoma multiforme has completed.
-
CLINICAL_TRIALS trial_result · 2017-12-18Clinical Trial Update: Engagement of Patients With Advanced Cancer [NA]
Clinical trial update noting engagement of patients with advanced cancer; status completed and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-12-13Clinical Trial Update: Antineoplaston Therapy in Treating Adults With Residual/Recurrent/Progressive Glioblastoma Multiforme [Phase 2]
Phase 2 study results for Antineoplaston therapy in adults with residual, recurrent, or progressive glioblastoma multiforme.
-
CLINICAL_TRIALS trial_result · 2017-11-01Clinical Trial Update: NOA-12: BIBF1120 and R-RT in Glioblastoma [Phase 1, Phase 2]
A Phase 1/2 trial evaluating BIBF1120 (nintedanib) with radiotherapy for glioblastoma multiforme has been terminated.
-
CLINICAL_TRIALS trial_result · 2017-09-19Clinical Trial Update: Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients [Phase 2]
Phase II trial of axitinib (AG-013736) in elderly patients with glioblastoma multiforme has been terminated; results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-07-12Clinical Trial Update: Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 clinical trial evaluating gossypol for progressive or recurrent glioblastoma multiforme; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-06-27Clinical Trial Update: Dasatinib and Bevacizumab in Treating Patients With Recurrent or Progressive High-Grade Glioma or Glioblastoma Multiforme [Phase 2]
Phase 2 trial evaluating dasatinib in combination with bevacizumab for recurrent or progressive high-grade glioma or glioblastoma multiforme…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Dasatinib or Placebo, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [Phase 1, Phase 2]
Phase 1/2 trial evaluating dasatinib or placebo with radiation therapy and temozolomide in newly diagnosed glioblastoma multiforme has compl…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: A Study of MEDI-575 in Subjects With Recurrent Glioblastoma Multiforme [Phase 2]
Phase 2 study of MEDI-575 in subjects with recurrent glioblastoma multiforme completed; results were posted on 2017-04-06.
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: Bi-weekly Temozolomide Plus Bevacizumab for Adult Patients With Recurrent Glioblastoma Multiforme [Phase 2]
A Phase 2 trial evaluating bi-weekly temozolomide plus bevacizumab in adults with recurrent glioblastoma multiforme and recurrent gliosarcom…